Table 1 Clinical and histopathologic characteristics of the Fudan DC cohort (n = 156)
Characteristic | n (%) | Parameter | n (%) |
|---|---|---|---|
Age | Survival status | ||
<50 yr | 38 (24.4) | Alive | 156 (100) |
50–70 yr | 101 (64.7) | Death | 0 (0) |
>70 yr | 17 (10.9) | Histopathologic (438 samples) | 325 (74.2) |
Gender | Epithelial components | ||
Male | 55 (35.3) | Yes | 325 (74.2) |
Female | 101 (64.7) | No | 113 (25.8) |
Smoking | Histology subtype | ||
Yes | 37 (23.7) | Adenocarcinoma (D) | 325 (74.2) |
No | 92 (59.0) | Brunner’s gland (G) | 97 (22.1) |
NA | 27 (17.3) | Heterotopic pancreas (P) | 1 (0.2) |
Drinking | Intermuscular gland (N) | 9 (2.1) | |
Yes | 30 (19.2) | Lymphangioma (L) | 2 (0.5) |
No | 93 (59.6) | Cystic dystrophy (C) | 3 (0.7) |
NA | 33 (21.2) | Neuroendocrine tumor (NET) | 1 (0.2) |
FAP | |||
Yes | 2 (1.3) | ||
No | 116 (74.4) | ||
NA | 38 (24.4) | ||
HNPCC | |||
Yes | 4 (2.6) | ||
No | 83 (53.2) | ||
NA | 69 (44.2) | ||
